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Introduction
The term ‘life course epidemiology’ was coined in 1997
with the publication of the first edition of A Life Course
Approach to Chronic Disease Epidemiology.1 This book
reviewed the pre-adult risk factors for cardiometabolic and
respiratory disease, the catalyst being the imaginative re-
search on the fetal origins of adult disease being driven for-
ward at that time by Professor David Barker. We defined
life course epidemiology as ‘the study of long-term biolo-
gical, behavioural and psychosocial processes that link
adult health and disease risk to physical or social exposures
acting during gestation, childhood, adolescence, earlier in
adult life or across generations’.1 Although our definition
of life course epidemiology has stood the test of time, the
field has evolved and there have been conceptual develop-
ments, methodological innovations which facilitate efforts
to test these concepts, and an increasing corpus of empir-
ical research demonstrating how factors from earlier life
are associated with later life health and disease, as well as
the pathways and biological mechanisms that may be
involved. These developments have generated further ideas
and challenges to life course models in an iterative process.
As the theme of this special issue suggests, one important
development has been the gradual shift of research focus
from clinical disease endpoints to multi-faceted traits and
longitudinal trajectories of functional phenotypes that can
be assessed well before any clinical threshold is reached.
This has naturally led on to the application of a life course
epidemiological approach to ageing. The purpose of this
overview is therefore to assess the development and current
state of the field of life course epidemiology, including its
recent application to the study of ageing as the focus of
this special issue.
Developments in the field of life course
epidemiology
Life course epidemiology is now recognized as a field of re-
search in its own right and was added to the fifth edition of
the Dictionary of Epidemiology.2 The original life course
book was to become the first in a series on a life course ap-
proach to adult health,3–8 as well as a journal glossary9
and chapters in a range of public health, epidemiology and
other academic textbooks.10–14 The original International
Journal of Epidemiology editorial on life course epidemi-
ology, published in 2002,15 is the fifth most highly cited
article in the journal’s history (search run on Web of
Science core collection 19 February 2016).
In order to chart key developments in the field, we have
drawn on our own experiences and the results of three lit-
erature searches: (i) a cited reference search of four key
conceptual life course publications,1,4,9,15 and Medline
searches for publications including the terms (ii) ‘life
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course’ and (iii) ‘developmental origin’ or ‘fetal origin’ (see
Box 1).
We have, from the outset, highlighted the long-term his-
tory of life course concepts and the fact that disciplines
outside epidemiology, such as demography, sociology, an-
thropology and psychology, have considered these broad
ideas for longer.3,9,16,17 (see commentary by Alwin18). It
was thus no surprise that our literature searches, even
when restricted to Medline, returned empirical as well as
narrative and review papers from journals in these discip-
lines as well as epidemiology and public health, highlight-
ing the broad appeal of a life course perspective.
Alwin18,19,20 discusses the conceptual and methodological
developments and the growth of empirical evidence in
these other fields and draws parallels with the develop-
ments in epidemiology.
Life course perspectives in epidemiology were eclipsed
in the mid 20th century by the almost exclusive focus on
the adult lifestyle model of disease causation.21 The cata-
lyst for the revival of life course thinking in epidemiology
was the seminal work of David Barker and colleagues on
the fetal origins of adult disease (FOAD)22 from the late
1980s, which was subsequently extended to the develop-
mental origins of health and disease (DOHaD) at the turn
of the century.23,24 The first of three phases in the develop-
ment of life course epidemiology reflects this: a focus on
the associations of early life factors with clinical disease
endpoints. Life course epidemiology is often incorrectly in-
terpreted as being synonymous with DOHaD, but there
are both similarities and differences (see below) and inter-
estingly there was only limited overlap found between pub-
lications in these two fields (see Figure 1).
We consider the second main phase in the development
of life course epidemiology to be the expansion of the field
to consider a wider range, and more integrated study, of
outcomes, including different aspects of physiological
Box 1. Reviewing the published literature
To assess developments in life course epidemiology since the inception of this term in 1997, we aimed to capture rele-
vant papers published in this area up to the end of 2014 using two searches (undertaken in February and March 2015):
1. A cited reference search of four publications on life course epidemiology (from the date of their publication to 31
December 2014):
I. Kuh D, Ben Shlomo Y (eds). A Life Course Approach to Chronic Disease Epidemiology. 1st edn. Oxford, UK:
Oxford University Press,. 1997.
II. Kuh D, Ben Shlomo Y (eds). A Life Course Approach to Chronic Disease Epidemiology. 2nd edn. Oxford, UK:
Oxford University Press, 2004.
III. Ben-Shlomo Y, Kuh D. A life course approach to chronic disease epidemiology: conceptual models, empirical
challenges and interdisciplinary perspectives. Int J Epidemiol 2002;31:285–93
IV. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C. Life course epidemiology. J Epidemiol Community
Health 2003;57:778–83
2. A free-text search to identify all literature indexed in Medline which:
• included the term: life course (i.e. ‘life ADJ course’ or ‘life-course’ or ‘lifecourse’), in the title or abstract;
• was published between 1 January 1990 and 31 December 2014;
• was published in the English language and indexed as study of humans.
To enable us to draw comparisons with developments in the Developmental Origins of Health and Disease (DOHaD) we
undertook a third search (in March 2015):
3. A free-text search to identify all literature indexed in Medline which:
• included the term: ‘developmental origin*’ OR ‘fetal origin*’ OR ‘foetal origin*’ in the title or abstract;
• was published between 1 January 1990 and 31 December 2014;
• was published in the English language and indexed as study of humans.
The results of each of these searches were downloaded to reference management software and duplicates were
removed. See Supplementary Figure 1 (available as Supplementary data at IJE online) for number of search results
returned.
Each result from search 2 was screened and classified by Y.B.S., R.C. or D.K. using standard criteria based on its rele-
vance, type of paper, outcome, exposure and analyses, timing of exposures and setting.
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function and their natural history across life, and of biolo-
gical, psychological and social risk factors acting independ-
ently, cumulatively or synergistically across different life
stages. These developments were possible because of the
growing number of birth cohort and other longitudinal
studies with increasingly rich data archives, and the devel-
opment of life course methods that facilitated such ana-
lyses. The study of functional measures is discussed further
below and this shift, alongside maturation of cohort stud-
ies with relevant data, has led to the third and most recent
phase in the development of life course epidemiology; the
application of a life course epidemiological approach to
the study of ageing.
There remains a healthy appetite for life course epi-
demiology after almost 20 years, and many of the ideas
proposed and subsequently developed remain scientifically
innovative and policy relevant. This is supported by evi-
dence of a year-on-year increase in the number of papers
that cite one of the four key references or use ‘life course’
in their title or abstract (see Figure 2). However, some cau-
tion is required as there has been a secular increase in the
number of scientific publications in general and when, clas-
sifying abstracts, we observed that the term ‘life course’ is
sometimes used loosely and occasionally inappropriately.
This supports the assessment made by Alwin in his review
of life course concepts in social sciences, that life course
‘has become a catch all term, taken to refer to all manner
of different aspects of individual experiences in biograph-
ical time’.18,19 In addition, it was noted that a number of
papers use the term ‘life course’ in their abstract despite
not applying this approach; rather, they have concluded
that this may be useful in future research. In contrast, some
of our own papers, that we would describe as examples of
life course epidemiology, were not captured by the
searches, as titles and abstracts of epidemiological papers
generally focus on reporting study design, exposures and
outcomes and do not necessarily report the conceptual ap-
proach taken: a limitation with current structured abstracts
and indexing.
Figure 1. Venn diagram showing overlap between search results.
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Figure 2. Number of publications identified by literature searches 1 and 2 by publication year.
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Despite these caveats, we identified trends in the pub-
lished literature which supported our observations on the
key phases of development in the field, and also provided
evidence of the balance between papers reporting empirical
studies and other types of papers. In the case of empirical
studies, we tried to capture the types of outcomes and ex-
posures and the settings in which the studies took place.
Key points are briefly summarized here, and relevant
points and publications uncovered by these searches are
cited throughout the paper. Approximately 60% of the
classifiable papers identified by our Medline search for
publications that included the term ‘life course’ in their
title and/or abstract (i.e. search 2) reported quantitative
empirical analyses (for breakdown of types of paper see
Supplementary Tables 1 and 2, available as Supplementary
data at IJE online).
Among these empirical papers there was evidence that
studies of metabolic conditions (including obesity and dia-
betes), cardiovascular and socioeconomic outcomes were
the most commonly investigated across all years; as were
studies of mental health25–27 where there has been a long-
standing parallel interest in the life course or life span per-
spective. There was evidence of a diversification in the
types of outcomes being studied over time, with more re-
cent empirical papers reporting life course analyses of a
wider range of outcomes including cancer, musculoskeletal
disorders, disability, oral health, injury, infectious diseases,
migration, genetic and epigenetic markers and age-related
phenotypic trajectories. There were also a number of
papers reporting on behaviours as outcomes: here cigarette
smoking, alcohol consumption and physical activity were
common, but other topics included marijuana use and
criminal behaviours, with several investigating these be-
havioural trajectories over different life stages.28–31
In terms of exposures, there has been an increase over
the past 10 years in the proportion of empirical studies
which model exposures as repeat measures or trajectories
covering multiple life stages. The impact of an adverse
socioeconomic environment in childhood and adulthood
on later outcomes remained an enduring theme, perhaps
because such exposures more easily lend themselves to
being modelled within a life course framework, have been
collected relatively frequently across life and can be retro-
spectively ascertained by a variety of methods. The impact
of early psychosocial environment, gender, body size and
shape and behavioural risk factors also appear to be per-
sistent topics. In terms of setting, the majority of studies
are based in the UK, mainland Europe and the USA, which
has been facilitated by the availability of data from matur-
ing birth and historical cohort studies, particularly in the
UK.32 More recently, there has been an increase in the
number of studies set in other high-income countries, and
also a rise in relevant studies being conducted in low- and
middle-income countries (see commentary by Tollman and
colleagues33). The broadening of study settings is essential
to help establish which life course associations are context-
ual and which are universal. A small but increasing number
of papers involved multiple cohorts (see below) which
sometimes crossed several of these settings.
From FOAD to DOHaD and the life course
We have always acknowledged the importance of the
‘Barker hypothesis’ or FOAD model as a stimulus for life
course epidemiology. We viewed this as one set of compet-
ing and innovative aetiological models that needed to be
tested alongside others. In addition, as population scien-
tists, understanding temporal, geographical and social dif-
ferences in disease risk is important, as well as elucidating
more fundamental downstream mechanisms that may ex-
plain epidemiological associations. We note that the term
‘life course’ has gained popularity in the DOHaD world
(anecdotal observation at the Eighth World Congress on
DOHaD, Singapore, 2013) and the term ‘life course biol-
ogy’ has been used by DOHaD colleagues,34 so it is im-
portant to understand what are the substantive similarities
and differences in approaches.
The DOHaD model proposes that responses to the im-
pact of any environmental challenge can be seen to operate
over different time scales: (i) homeostasis is the immediate
response; (ii) predictive adaptive response (PAR) occurs in
earlier life and maximizes the chances of survival and re-
production; and (iii) natural selection occurs over many
generations.24,35,36 Chronic disease may arise where a PAR
is maladaptive in the long term, e.g. a PAR to a nutrient-
poor environment in childhood will be counter-productive
if the adult environment is obesogenic and so could lead to
type II diabetes. This is analogous to the ‘antagonistic plei-
otropy’ model of ageing, whereby pleiotropic genes with
good early effects would be favoured by selection even if
these genes had bad effects at later ages as long as the or-
ganism had successfully passed on these genes to future
generations.37 The ‘live fast, die young’ strategy is success-
ful when there are strong external influences on mortality
so that few survive much beyond reproductive age. Both
models assume that survival into later life has no benefits
on the survival advantage of first- or even-second gener-
ation offspring. This may not be true for human societies
where kinship networks can play an important role in the
health and well-being of children and grandchildren, espe-
cially in low- and middle-income countries where the rav-
ages of HIV infection have left generations of children
dependent on grandparents for care. We agree with a re-
cent DOHaD review paper37 which argued that the early
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use of the term ‘programming’ was unhelpful in implying
an overly deterministic view of DOHaD, and was not sup-
ported by the empirical evidence.
Scientists concerned with life course epidemiology or
the DOHaD approach share many common research inter-
ests, especially in understanding how developmental fac-
tors are associated with adult function and disease, but
there are important differences. Life course epidemiology
is equally interested in the maintenance of function or its
rate of decline post maturity and the factors across the
whole of life that determine this. The focus of DOHaD is
on developmental mechanisms within an evolutionary
framework, but whereas this framework is a scientific
strength and is widely relevant to many outcomes, research
has focused on the developmental origins of chronic dis-
eases, especially cardiometabolic diseases. In contrast, life
course epidemiology with its public health background re-
mains interested in both social and biological pathways,
and has been applied to a wider variety of outcomes, as
evidenced by our literature searches. DOHaD, despite its
growing interest beyond the immediate postnatal period,
has focused on interventions in young and/or pregnant
women or in infancy, generally with a biomedical em-
phasis, and has been somewhat dismissive of the potential
for later life interventions to modify disease risk or alter
disease progression. A life course approach is essentially
agnostic and tries to provide empirical evidence to guide
the most appropriate timing of any intervention, be it at a
biomedical, individual or societal level, to maximize popu-
lation health. The DoHAD approach has been more suc-
cessful in engaging the basic science community, but the
life course approach has also benefited from interdisciplin-
ary interactions with basic scientists: for example, research
relating to the insulin-like growth factor cancer inter-
relationship and how it has influenced life course studies in
human populations (summarized in reference12). The com-
mentary by Boyce and Shonkoff38 reinforces the need to
triangulate life course epidemiology with mechanistic in-
sights from biology. We believe that both approaches have
much to offer each other, despite the limited overlap in the
literature to date (see Figure 1), and anticipate further con-
vergence in how ideas from both camps can be used to
cross-fertilzse future research (see commentary by Hanson
and Gluckman for further discussion39).
Revisiting life course models
In our original work we proposed several conceptual mod-
els such as critical/sensitive period models, as exemplified
by DOHaD, and accumulation or chains of risk models
which are more common in the social epidemiology litera-
ture. We illustrated these ideas graphically using simplified
causal diagrams, though at this time we were unaware of
the growing literature on directed acyclic graphs
(DAGs),40,41 (see commentary by De Stavola and Daniel42
for a more detailed discussion of causal inference in rela-
tion to life course concepts and VanderWeele’s unified ap-
proach to decomposing exposure outcome relationships in
the presence of mediators and potential interactions43).
Initially these critical period and accumulation models
were presented as different classes of models, though we
have since noted11 that it is more sensible to view critical
or sensitive period models as special sub-sets of an accumu-
lation model when considering the effects of an exposure
over time—hence, the effects of exposures over different
time periods do not add up in a simple additive fashion but
differ in the strength of effect in a quantitative sense (sensi-
tive period) or in a qualitative sense, so that they can only
be observed in one time period (critical period) (a point
also made by Alwin20).
In our initial work, we had conceptualized an accumu-
lation of risk as the incremental burden of different expos-
ures with age, and highlighted the issue of clustering of
exposures. However, our literature searches highlight that
most papers that try to address this model actually use the
cumulative exposure of a single exposure, such as periods
of adverse social circumstances, in a quantitative fashion.
This is a standard epidemiological approach (‘dose-
response effect’) and of particular interest to occupational
or environmental epidemiology. Even here, arguments per-
sist as to how best to model the functions of intensity and
duration.44 A life course approach highlights the import-
ance of timing over and above cumulative exposure. We
have illustrated this with a simple figure (see Figure 3)
examining the relationship between pack-years of smoking
exposure and breast cancer risk. A conventional dose-
response model would be consistent with an accumulation
model. However, it would fail to recognize a sensitive
period model if it did not consider whether initiation of
smoking during puberty or post-pubertally altered the risk
conditional on smoking intensity and duration.45 Of
course there may be other potential mechanistic pathways
so that early and intense smoking may itself predict expos-
ure to smoking at the time of disease onset, and hence the
induction may be relatively short but predicted by early
smoking behaviour.
Many contemporary papers have formally modelled tra-
jectories of exposure, especially those examining anthropo-
metric exposures, using a variety of statistical approaches
(for example two-stage spline models, latent class models,
multilevel models, SITAR—see reference Tu et al. 201346
for a review of this area and accompanying commentary
by Hardy and Tilling47) to see whether different exposure
patterns are associated with risk. As an exemplar, one can
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then pose the question as to whether the chronic disease
risk associated with midlife obesity is different for those
sub-groups who have always been at the upper end of the
body mass index (BMI) distribution and have tracked into
adulthood, versus those who were born underweight and
gained weight in childhood or early or mid adulthood. An
alternative has been to use a Mendelian randomization ap-
proach which uses genetic markers as instruments for be-
havioural or phenotypic variability, thereby exploiting the
random allocation of parental genotype and avoiding
issues of confounding and reverse causation.48–50
The notion of a critical/sensitive period was initially
framed around early life, stimulated by FOAD. It is in-
creasingly being shown that biological and social transi-
tions during other life stages are also likely to be sensitive
periods where adverse exposures may have more impact
than at other times, as birth cohort studies have matured
and cohorts with rich data on adolescence, young adult-
hood and mid life51–53 have emerged. For example, the
timing of the pubertal growth spurt appears to be import-
ant for levels of insulin-like growth factor-I,51 breast can-
cer risk54 and trabecular volumetric bone mineral
density.55 Accelerated increases in blood pressure across
early and mid adulthood are associated with a greater left
ventricular mass index and indicators of diastolic dysfunc-
tion in early old age.56 Identifying sensitive periods can be
difficult, but will be helped by a better understanding of
phenotypic/functional trajectories (see below), as inflection
or turning points in a trajectory may highlight the greater
value of an intervention, assuming this is at least partially
modifiable and driven by concurrent exposures.
Life course models have also stimulated statistical meth-
ods to help differentiate between various competing mod-
els. These have used nested models,57 causal inference
algorithms,58 least-angle regression,59 structural equation
models60 and marginal structural models.61 Any life course
model which considers exposures, confounders and poten-
tial intermediaries is bedevilled by the problem of time-
varying confounders and ‘intermediary confounders’,62 i.e.
a confounder of a mediator which is itself affected by the
exposure and hence also acts as an intermediary. This
problem is not specific to life course epidemiology but is
obviously more problematic when examining exposures
acting over a long time period, for example when testing
whether cognitive function in adulthood is associated with
mortality rates, given the large number of social and be-
havioural covariates that could act in several different
ways.63
The drivers and consequences of functional
change
The original life course models generally assumed a fixed
outcome, such as disease diagnosis at a point in time.
However, as noted above, lifetime trajectories of func-
tional phenotypes are increasingly being studied as out-
comes. This shift in focus has been driven in part by our
initial work which put forward hypothetical phenotypic
trajectories, adapted from Strachan’s review of lung func-
tion in the original life course textbook.64 These illustrate
how the same disease endpoint could be reached through
either suboptimal development or accelerated decline or a
combination of both. At that time these patterns were
hypothetical, but recent data have identified that around
half of all cases of chronic obstructive pulmonary disease
occur in individuals with suboptimal adult lung function
but normal age-related decline, whereas the other half
occur after normal development of lung function with an
accelerated decline phase.65 This simple figure highlighted
two important messages: (i) that epidemiologists should
consider continuous traits, such as lung, cognitive or
muscle function and complex phenotypes such as ageing,
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as well as binary phenotypes; and (ii) that classifying dis-
ease endpoints at one time period, usually in later life, ig-
nores the underlying trajectories, thereby increasing
phenotypic heterogeneity. This will attenuate risk factor
associations if they are only of causal relevance for some
sub-groups but not others. The same argument has been
made for understanding phenotypic variability in relation
to genetic association studies.66 Using functional outcomes
also has the benefit of facilitating the study of preclinical
disease and identifying high risk sub-groups through risk
stratification; functional outcomes may have more statis-
tical power; they demonstrate the dynamic nature of dis-
ease aetiology with periods of recovery as well as loss; and
they can be used for clinical triage. Being able to detect
early markers of suboptimal development and/or an accel-
erated trajectory of functional decline before it is clinically
manifest is fundamental to a life course perspective, be-
cause it offers an opportunity to delay the rate of decline
and/or the onset of functional impairments through pre-
ventive strategies. How these trajectories differ with person
(age, gender, social circumstances), place (geography) and
time (birth cohorts) may all provide important mechanistic
and aetiological clues for further investigation.
Where the drivers of functional change are themselves
changing over time, joint modelling of both trajectories of
exposure and phenotype and their inter-relationship is
required.67 For example, data from the ALSPAC birth co-
hort has been used to model how maternal change in blood
pressure during pregnancy may relate to offspring blood
pressure trajectories between 7 to 18 years, using bivariate
linear spline models.68 In this case there is no problem with
temporality, as offspring trajectories cannot influence ma-
ternal patterns. However, when studying functional trajec-
tories that may be occurring simultaneously, for example
cognitive and physical function, it is unclear which should
be regarded as the driver and which the consequence; in-
deed both may drive each other.69 The hypotheses to test
may be taken for theoretical and pragmatic reasons, such
as the ages when data points are available; however, inter-
pretation of findings needs to acknowledge the inherent
challenges of identifying the temporal ordering in these
situations.
The research evidence on functional change within a life
course context is less developed (see this reference70 for
evidence of change in cardiometabolic outcomes). It has
been harder and more costly to achieve, due to the require-
ments for multiple and frequent measures, though this may
be changing due to technological innovations. Not surpris-
ingly this has resulted in gaps around several important
questions. So, for example, to what degree do earlier life
factors that have been previously shown to be associated
with the level of adult function, also drive functional
change, or is the association merely due to the maximal
level attained through developmental factors? Smaller
birthweight is associated with higher blood pressure but
this does not appear to amplify with age, suggesting that
the age-related increase is similar regardless of birth-
weight.70,71 In contrast, early adverse social circumstances
are associated with greater increases in blood pressure in
mid life,72 perhaps through an influence on BMI gain.
One of the inherent problems of characterizing lifetime
functional trajectories and their inter-relationships is the
need for longitudinal data across the whole life course,
which are rarely available. Alternatives include the use
of cross-sectional data from a single study with a very wide
age range, or the creation of a synthetic birth cohort
by combining cross-sectional and/or longitudinal data
from multiple cohorts covering different age ranges usu-
ally with some overlap. Both approaches have been under-
taken to establish normative data on grip strength across
life.73–75 To understand within-person change, one
must combine longitudinal data across different ages as
was undertaken by Wills et al.76 using blood pressure
data from eight British cohort studies. Interestingly, par-
ticipants in the only occupational cohort (Whitehall II
study) had a more moderate/less marked mid life increase
in blood pressure, suggesting modifiable social determin-
ants, unless this was due to selection bias. By drawing to-
gether data from different cohorts, alcohol consumption
patterns have also been shown to change with age in a
similar way for men and women, but men have a higher
peak level.77
By concatenating data from overlapping age groups
from different cohorts,73 or simply using cross-sectional
data covering a wide age range,74,75 we are assuming that
there are no period or cohort effects which may not be
true. This can be formally tested when different birth co-
horts with data across the same age periods are directly
compared with each other. Johnson et al.78 harmonized re-
peat measures of body size from five British birth cohorts
from the CLOSER consortium, born in 1946, 1958, 1970,
1990–92 and 2001, and showed that the probability of
being overweight or obese increased rapidly after child-
hood in the oldest three cohorts; the probabilities of over-
weight in the two younger cohorts at 11 years were already
double those in the three older cohorts; and the shifts in
age-related overweight or obesity trajectories across these
cohorts was due to BMI being positively skewed in the
more recent cohorts. The earlier onset of obesity78 and
hence greater obese life-years79–81 in more recent cohorts
can be used to predict future disease burden and demands
on health service delivery. Such cross-cohort collaborations
with re-analysis of individual participant data are ex-
tremely valuable, but technical issues around data
International Journal of Epidemiology, 2016, Vol. 45, No. 4 979
harmonization as well as the important assumptions when
aggregating data should not be under-estimated.
The challenge of ageing research for life
course epidemiology
Applying life course ideas to ageing research has made us re-
consider and modify some of our earlier, simpler life course
models. How one defines and measures ageing remains
debated, with much interest in developing biomarkers82 of
biological as opposed to chronological age. These can be
single biological markers of a cellular process, e.g. telomere
length or epigenetic clock,83 but are more often composite
markers that aggregate determinants and/or consequences
of ageing.84,85 In each case the aim is to demonstrate that
the marker has added value in predicting other outcomes,
such as mortality, morbidity or function, over and above
chronological age. The predictive value of these markers
may differ at different stages of the life course and may not
necessarily remain constant over secular period; and as with
any other markers of continuous traits that show population
variation and age-related changes, they should be studied
from a life course perspective.
We have noted that there is a lot of confusion about what
is meant by the term ‘healthy ageing’, partly because re-
searchers are trying to do two things. Some researchers in-
clude any dimension of the health and well-being of older
people regardless of whether the health dimension under
study changes adversely with age. Others, including our-
selves,5 separate out healthy biological ageing from how peo-
ple feel or function socially, preferring to study their bi-
directional relationships rather than derive some composite
healthy ageing index. Ageing is expressed as a failure to main-
tain structural or functional integrity, leading to system fail-
ure and ultimately death. Healthy biological ageing covers
three key longitudinal components: survival to old age, delay
in the onset of age-dependent diseases, and maintenance of
optimal functioning for the maximum period of time. We dis-
tinguish three levels of functioning that all generally show a
decline with age: capability describes physical and cognitive
functioning at the individual level, and is defined as the cap-
acity to undertake the physical and mental tasks of everyday
living; the physiological functioning of each body system; and
the underlying functioning of molecules and cells. Studying
the lifetime trajectories of these different aspects of function-
ing, their dynamic interplay over time, and their lifetime en-
vironmental and genetic determinants has become a major
focus in life course epidemiology.
Ferrucci and Studenski86 have proposed a model for
understanding frailty or healthy life expectancy that
focuses on four key ageing phenotypes: (i) central nervous
system (CNS) integrity or neurodegeneration; (ii) homeo-
static regulation or age-related dysregulation in signalling
pathways that maintain homeostasis (encompassing both
the endocrine and immunological systems); and age-related
changes in (iii) body composition (muscle, fat and bone)
and (iv) energy capacity and consumption. We have incor-
porated these themes into an integrated life course model
of ageing (see Figure 4). We have also added reproductive
ageing (not normally considered by gerontologists), given
the importance of development and reproduction from an
evolutionary perspective, and emotional health which itself
may be a determinant and/or consequence of ageing but is
important for social participation and quality of life. A
woman’s physiological response to the challenge of preg-
nancy and childbirth provides insights into adaptive cap-
acity, and reproductive characteristics (such as gestational
diabetes, offspring low birthweight and early menopause)
that may act as sentinels for later disease and accelerated
ageing.87
We delineate six phases of life (conception, pre-natal,
pre-pubertal, pubertal, maturity and senescence) though
we recognize the importance of inter-generational influ-
ences through genetic, epigenetic or social transmission.
The other dimensions are what we refer to as the external
and internal environments, the former referring to the so-
cial and physical milieu which will in turn influence and
interact with the latter. This may operate via: direct
physiological change, e.g. weight loss due to famine; or
through internal adjustment or modification, e.g. down-
regulation of the growth hormone insulin-like growth fac-
tor axis in relation to dietary exposure,88 analogous to the
PAR with potentially long-term adverse or beneficial
consequences.
Not surprisingly these are dynamic systems with feed-
back loops that can operate in both negative and positive
ways to either maintain stability and homeostasis or to in-
crease deviation and instability, a feature seen in ageing
systems. Our own work89 used simple epidemiological
measures of physical and cognitive capability and of emo-
tional wellbeing, as these are easy to measure in large-scale
epidemiological studies. Comorbid disease such as chronic
obstructive pulmonary or cardiovascular disease will usu-
ally impact on these measures as well as influencing body
composition and energetics. CNS integrity is clearly im-
portant for cognitive function but also plays roles in phys-
ical capability through neuromuscular coordination and
through endocrine and autonomic pathways. The ‘com-
mon cause hypothesis’ argues that ageing is associated
with decline across multiple systems through common
aetiological mechanisms, be they genetic or environmental.
This may not always be evident, as the rate of decline may
differ across domains so that one system, e.g. cognitive
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decline, may appear to be more dominant even though
physical decline is also present. Some evidence exists for
the common cause hypothesis, though a recent systematic
review69 found only modest evidence and also issues
around comparability between studies.
The stochastic nature of ageing means that this inte-
grated life course model is unlikely to predict individual
outcomes with much certainty, but it may explain group
differences in ageing.90 This generic model had three
phases: (i) growth; (ii) plateau; and (iii) degeneration,
analogous to Baltes’ allocation of resources across the life
course—with allocation of resources towards growth in
childhood, maintenance and recovery (resilience) in adult-
hood and regulation or management of loss in old age91
(see also commentary by Alwin18). This simple pattern
may not always apply; for example, systolic blood pressure
shows an accelerated increase with age with a possible de-
cline by the eighth decade.76 It is possible to reconcile this
divergent pattern by reconceptualizing the phenotype to be
arterial elasticity, rather than systolic blood pressure. This
will decrease with age, hence resulting in increased systolic
blood pressure. The apparent decrease in blood pressure in
later life, assuming this is not a treatment effect, is not due
to increased elasticity but more likely reflects a different
pathophysiological mechanism such as declining auto-
nomic control on vascular tone. However, this generic
pattern may not be true for all systems and structures.
Cross-sectional and longitudinal MRI scans of the brain
suggest more variable patterns. Brain volume appears to
increase in the first part of life, presumably due to myelin-
ation and axonal growth but, before the maturational
changes are complete, degeneration due to selective loss of
small-diameter myelinated axons (primary degenerative
event) and demyelination of larger connections (secondary
degenerative event) occurs. The superimposed effect of
both processes result in an early period whereby the vol-
ume increase slowly decelerates and a later period, where
volume reduction begins to level off.92 Different brain
structures, however, showed different trajectories; the
hippocampus showed a plateau and then accelerated loss
pattern whereas the cerebral cortex had a simple linear de-
cline (at least from age 20 years).
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Physiological, psychological and social
resilience
We know there is great heterogeneity in biological ageing
and our models, to be of any value, need to be able to take
into account this variation in resilience to environmental
challenges with age. The ability to repair and compensate
was referred to by Martin93 as ‘sageing’, though he con-
sidered this to only occur in the phase between that of the
mature, reproducing adult and the senescing adult. We
would argue that this view is too limited and in fact this
can occur throughout life though the relative ease and abil-
ity to compensate may well differ (sensitive periods) and is
generally regarded to decline with age (known as ‘homeo-
stenosis’).94 A life course approach is particularly inter-
ested in understanding the relationship between the
growth, plateau and degeneration phases. Are they inde-
pendent or do similar or different risk factors determine
them? Is there an interaction between these phases and
clinical disease or functional limitations?
One obvious relationship is the role of what we have
previously described as structural reserve; those with better
development of a phenotype (e.g. lung function, bone
mass, cognitive capability) will have further to decline be-
fore reaching any impairment threshold and hence will pre-
sent with disease at a later age, or may never present if
they die of another cause. In our original figure this was
illustrated by the peak level of function at the plateau
phase. We failed to illustrate the ability to recover from ad-
verse exposures and how this changes with age, what we
now term as compensatory reserve (see Figure 5).
Although such short-term responses will be beneficial,
there may or may not be longer-term costs in relation to
ageing. McEwen and Wingfield described this longer-term
adverse effect as type 2 chronic allostatic load.95
Thus, the degree of heart failure subsequent to a heart
attack will not only depend on the size of the infarction
and how healthy it was before this event (premorbid state)
but also the post-ischaemic response in generating collat-
eral circulation thereby salvaging cardiac muscle and func-
tion. Intrinsic compensatory reserve may or may not be
related to structural reserve, an empirical question that re-
quires attention. For example, does recovery post stroke
relate to developmental pre-stroke synaptic connectivity or
does it merely reflect acute central repair processes?
Similarly, is age-related loss of immune responsiveness to
novel antigens related to the degree of immunostimulation
in early life? In order to capture adaptive responses, it is
necessary to physiologically stress the system. This may be
a natural process, as seen in the rise in cortisol levels on
waking (cortisol awakening response) or through a
standardized exposure such as the oral glucose tolerance
test to measure glucose and insulin responsiveness to a
standard intake. Few studies have made use of other op-
portunistic dynamic exposures, such as immune respon-
siveness to flu vaccination,96 blood pressure decline in
response to antihypertensive agents, or recovery from an
acute event such as illness or surgery. A recent interesting
exemplar was a study of the impact of acute stroke on lon-
gitudinal cognitive trajectories.97 Three distinct patterns
emerged: (i) acute decline but no change in age-related de-
cline (seen with word learning list and recall); (ii) acceler-
ated age-related decline (seen with executive function); and
(iiii) both acute decline and accelerated age-related decline
(seen with global cognition).
Old age is obviously associated with greater morbidity
often necessitating major health care interventions. Recent
evidence highlights the predictive value of the pre-
admission physical trajectory in predicting 1-year survival
after an acute illness resulting in an intensive care unit epi-
sode.98 Greater understanding of how functional trajecto-
ries predict clinical outcomes would enhance precision
medicine. Better selection of those who have most to bene-
fit from an intervention would not only reduce health care
expenditure but also avoid unnecessary and often invasive
procedures for patients and families. Other predictors of
post-surgical outcomes also illustrate the often paradoxical
nature of mid life risk factors in older populations. Being
overweight and obese in mid life increases premature mor-
tality risk, but at older ages both are associated with
reduced postoperative mortality compared with normal
weight after elective joint replacement.99,100 Whether this
reflects a healthy survivor effect, confounding by comor-
bidity101 and smoking status or a genuinely protective ef-
fect of greater lean mass which is positively correlated with
fat mass, in response to the acute trauma of surgery, re-
mains to be determined.
In parallel, how an individual responds to adversity will
result in extrinsic compensatory adaptations which may be
facilitated or hindered by the external environment. Baltes
proposed a meta-theory known as the selective optimiza-
tion and compensation (SOC) model to understand human
development. In addition, he stated ‘with age, and condi-
tioned primarily by the negative biological trajectory of the
life course, the relative power (effectiveness) of psycho-
logical, social, material and cultural interventions
wanes.’91 This ability of individuals to optimize and com-
pensate will be determined by a variety of factors; psycho-
logical trait (self-efficacy), educational resources (health
literacy), material resources (socioeconomic position), fa-
milial and social resources (inter-connectedness) and geo-
graphical factors acting on the household, neighbourhood
and locality. For example, higher socioeconomic position,
social networks and residential location may facilitate
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engagement with intellectual pursuits which in turn could
maintain synaptic connectivity through cognitive stimula-
tion, and hence slow down decline or maintain cognitive
function independent of cognitive reserve, in the presence
of underlying neurodegeneration.
Variability over varying timescales
The other limitation of our illustration of different trajec-
tory patterns is that this merely represents the mean trajec-
tory and fails to illustrate variability (measured over
seconds, minutes, hours, days, weeks) which may provide
added predictive value for phenotypic integrity. Blood
pressure variability for a given identical mean level inde-
pendently increases risk of cardiovascular disease,102 pos-
sibly because it is a marker of arterial stiffness which
predicts cardiovascular morbidity independent of mean
blood pressure103 or is also a marker of failing central
homeostatic mechanisms that maintain blood pressure
within a limited range. Similar observations have been seen
for gait speed in older populations in which a larger stand-
ard deviation of gait speed rather than mean level predicts
future falls risk104 and probably reflects underlying neuro-
logical dysfunction. Past epidemiological studies have not
been able to capture variability, especially not on a day-to-
day basis, because of the prohibitive cost and respondent
burden except in small-scale detailed studies. New technol-
ogies now make this a feasible proposition although our
understanding of the life course determinants of such com-
pensatory responses is currently limited. Whether these are
modifiable is clearly important; we know from the LIFE
trial that increased physical activity in high-risk older peo-
ple can reduce the incidence of mobility disability, al-
though this was not associated with a reduction in
hospitalization.105
Current challenges of life course
epidemiology
This review has shown that the field of life course epi-
demiology has a healthy scientific agenda focused on
understanding how different aspects of function change (at
the individual, system and cellular levels) across life, and
on discovering their lifetime risk factors, mediators, modi-
fiers and consequences. Much of this agenda is shared with
our colleagues in DOHaD, in ageing research (see com-
mentary by Newman106) and in geroscience (see commen-
tary by Ferrucci107,108) and we believe our complementary
approaches add value and hence should be further inte-
grated. This scientific agenda attracts researchers from
many disciplines, and the demographic pressures of an age-
ing population on health and social care should ensure a
parallel political agenda on the importance for these re-
search streams.
A healthy scientific agenda ensures continuing techno-
logical developments which in turn provide new opportu-
nities for life course epidemiology and for epidemiology
more generally. We give a few examples. Technology or
‘digital epidemiology’109 increasingly allows us to capture
real-time dynamic assessments of function, environment
and behaviour which provide additional information on
short-term variability within the context of long-term
change. There are growing opportunities for exploiting re-
cord linkage, assuming ethical issues and consents have
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been addressed, which reduce respondent burden and in-
herent problems of self-reporting. This has additional
added value in enhancing analyses that incorporate missing
data, always an in issue in any longitudinal study, and help
produce less biased estimates of effect as seen recently with
data from the ALSPAC study.110
A priority is to find ways to capture the care pathways
and the interactions between individuals and their experi-
ence of health and social care that may shape future func-
tional trajectories; for example, how dynamic events, such
as acute illness and the care received at that time, punctuate
trajectories of decline in later life.111 Life course and longitu-
dinal methods are being used to harness the ‘omics’ revolu-
tion to this scientific agenda in the hope that new
aetiological insights into underlying biological pathways
linking earlier exposures to later function will be gener-
ated112 and new quantitative biomarker profiles will predict
age-related functional change and disease development (also
see IJE special editions on epigenetics and Mendelian ran-
domization50,113). Any future review of life course epidemi-
ology will need to evaluate the success of these approaches
in addressing these scientific questions.
Past, current and future developments in life course epi-
demiology and in life course cohorts are intimately inter-
twined: since the 1990s, there has been a ‘feast’ in terms of
the growing number of cohorts with increasingly rich data
archives (social and biomedical) for testing life course
hypotheses; this has helped to maintain and continually
evolve the scientific agenda (see editorial by Brayne114).
We see a number of challenges ahead for cohort studies in
a time of financial austerity. Each cohort study must justify
its scientific niche, as well as maximize its value from
cross-cohort collaborations, especially with the rise of
large biobank studies. In the ideal world, both types of
study are required as they are complementary, but in the
real world they compete for limited resources. Recent cuts
to cohort funding and/or challenges in participant recruit-
ment are cause for concern115,116 and will do little to at-
tract a new generation of primary investigators to invest in
cohort management, collect and assess data quality, and
incorporate new life course methods of statistical analysis
so that the benefits of longitudinal data on more granular
exposure and outcome data can be best realized.
Another challenge is to translate the growing body of
evidence on the lifetime influences on adult health, disease
and ageing into practice or policy-relevant guidelines and
intervention studies to improve the population health117
(see commentaries by Boyce and Shonkoff38 and Aihie
Sayer and Gill118). Strategic and policy documents increas-
ingly espouse a life course perspective and cite evidence
from cohort studies,119 though this is usually within an
early life remit focusing on maternal and child
health,117,120 both important areas in their own right.
However, some research funders, policy makers and gov-
ernments consider that the translational agenda is not
moving fast enough. Life course epidemiology has mainly
relied on observational studies or, rarely, the opportunistic
long-term follow-up of randomized controlled tri-
als.88,121,122 It may also be that the implications from life
course research, for example about the long-term effects of
adverse socioeconomic and psychosocial environments,
may not be attractive to politicians who seek short-term
wins that are achievable within an electoral cycle. Finally it
is important to remember that some life course findings
may be highly context specific, in both time and place,
making generalizing from observations to policy formula-
tion problematic. Systematic reviews and cross-cohort
comparisons are important and necessary pre-requisites be-
fore assuming immediate policy relevance.123,124
An eminent professor of epidemiology once com-
mented, after one of our presentations, that whereas they
really liked the concepts underpinning life course epidemi-
ology, they were concerned that the data and analytical de-
mands in testing these concepts may make our goals
unachievable. We have always shared this concern but
have been encouraged by the enthusiasm of researchers in
rising to this challenge. We believe that in this new era of
‘big data’ and genuine multidisciplinary research groups
with new disciplinary partners, such as computer scientists,
engineers and mathematicians, we are in a far healthier
place to take on these complexities. The new discoveries
emerging from the ‘omics’ revolution need to go hand and
hand with historical, current and future cohort studies,
thereby allowing us to understand the interplay of molecu-
lar, system, individual and societal factors on development
and maintenance of health and function as well as disease
aetiology.
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Introduction
The ‘life course epidemiology’ (LCE) approach articulated
by Ben-Shlomo, Cooper and Kuh (BCK) in their review (this
special issue of IJE) is one among several substantive para-
digms that are informed by the concept of ‘life course’. It is
an important subfield of epidemiology that focuses on the
processes (biological, behavioural, psychosocial) that link
adult health and disease risks to early life events and expos-
ures. In recent years, the key themes in this work have
drawn the attention of numerous scholars from several dif-
ferent disciplines.1–7 Despite competing theories and nuanced
differences in empirical findings, the literature consistently
suggests that individual differences in adult health depend in
important ways on early life experiences—increasingly
referred to as ‘the long arm of childhood’.8–10 An emerging
consensus concludes that the influences of such factors ex-
tend well into adulthood through exposure to conditions
that differentially shape the risks of disease and access to pro-
tective factors over the entire life span.
The increase in life course thinking has been remarkable in
its abundance and diversity. This is supported by a recent re-
view based on Web of Science data that provide trend lines for
three fields: sociology, psychology and epidemiology since the
early 1990s.11 These results make a persuasive case for the
proliferation of the term ‘life course’ in research over the past
two to three decades, especially in the field of epidemiology
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